Alcor: FAQ – Technical

Index - 1.General - 2.Technical - 3.Ethical - 4.Spiritual 5.Financial - 6.Membership - 7.Misinformed See also Scientists' Cryonics FAQ

Q: What are nanotechnology and nanomedicine?

A: Molecular nanotechnology is an emerging technology for manufacturing and manipulating matter at the molecular level. The concept was first suggested by Richard Feynman in 1959. The theoretical foundations of molecular nanotechnology were developed by K. Eric Drexler, Ralph Merkle, and others in the 1980s and 1990s. More recently the future medical applications of nanotechnology have been explored in detail by Robert Freitas in his books, Nanomedicine Vol. I (Basic Capabilities) and Nanomedicine Vol. IIA (Biocompatibility). These scientists have concluded that the mid to late 21st century will bring an explosion of amazing capabilities for analyzing and repairing injured cells and tissues, similar to the information processing revolution that is now occurring. These capabilities will include means for repairing and regenerating tissue after almost any injury provided that certain basic information remains intact. A non-technical overview of nanotechnology, including an excellent chapter on cryonics ("biostasis"), is available in Eric Drexler's book, Engines of Creation.

|top|

Q: Won't memories be lost if brain electrical activity stops?

A: Short-term memory depends on electrical activity. However long-term memory is based on durable molecular and structural changes within the brain. Quoting from the Textbook of Medical Physiology by Arthur C. Guyton (W.B. Saunders Company, Philadelphia, 1986):

We know that secondary memory does not depend on continued activity of the nervous system, because the brain can be TOTALLY INACTIVATED (emphasis added) by cooling, by general anesthesia, by hypoxia, by ischemia, or by any method, and yet secondary memories that have been previously stored are still retained when the brain becomes active once again.

This is known from direct clinical experience with surgical deep hypothermia, for which complete shutdown of brain electrical activity (electrocortical silence) is not only permissible, but desirable for good neurological outcome.

See the article here:
Alcor: FAQ - Technical

Related Posts

Comments are closed.